Re: Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma.
作者信息
Sherif Amir
出版信息
Int Braz J Urol. 2007 Nov-Dec;33(6):840-1. doi: 10.1590/s1677-55382007000600015.
Abstract
摘要
相似文献
1
Re: Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma.
Int Braz J Urol. 2007 Nov-Dec;33(6):840-1. doi: 10.1590/s1677-55382007000600015.
2
Neoadjuvant Chemotherapy With Gemcitabine and Cisplatin for Plasmacytoid Urothelial Bladder Cancer: A Case Report and Review of the Literature.
Clin Genitourin Cancer. 2016 Feb;14(1):e103-5. doi: 10.1016/j.clgc.2015.08.009. Epub 2015 Sep 3.
3
Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma.
Int Braz J Urol. 2007 Sep-Oct;33(5):630-8; discussion 638. doi: 10.1590/s1677-55382007000500004.
4
Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer.
Cancer. 2015 Aug 1;121(15):2586-93. doi: 10.1002/cncr.29387. Epub 2015 Apr 14.
5
Gemcitabine and cisplatin in locally advanced and/or metastatic bladder cancer.
Eur J Cancer. 2000 Jul;36 Suppl 2:13-6. doi: 10.1016/s0959-8049(00)00080-0.
6
Editorial comment on: Long-term survival after gemcitabine and cisplatin in patients with locally advanced transitional cell carcinoma of the bladder: focus on supplementary treatment strategies.
Eur Urol. 2007 Aug;52(2):486-7. doi: 10.1016/j.eururo.2007.03.017.
7
Neoadjuvant Chemotherapy for Patients with Muscle-invasive Urothelial Bladder Cancer Candidates for Curative Surgery: A Prospective Clinical Trial Based on Cisplatin Feasibility.
Anticancer Res. 2017 Nov;37(11):6453-6458. doi: 10.21873/anticanres.12100.
8
Expression of nucleoside transporters and deoxycytidine kinase proteins in muscle invasive urothelial carcinoma of the bladder: correlation with pathological response to neoadjuvant platinum/gemcitabine combination chemotherapy.
J Urol. 2014 Jan;191(1):35-9. doi: 10.1016/j.juro.2013.07.006. Epub 2013 Jul 10.
9
Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: a retrospective analysis from the University of Southern California.
Urol Oncol. 2013 Nov;31(8):1737-43. doi: 10.1016/j.urolonc.2012.07.005. Epub 2012 Nov 7.
10
Open-label randomized multi-center phase 2 study: gemcitabine cisplatin plus avelumab or gemcitabine cisplatin as first-line treatment of patients with locally advanced or metastatic urothelial bladder carcinoma: GCisAve.
Bull Cancer. 2020 Jun;107(5S):eS1-eS7. doi: 10.1016/S0007-4551(20)30280-0.
Zotero 插件